Inside, between rows of incubators and microscopes, Beth Shapiro and her team are attempting a feat straight out of science ...
Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...
Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.
Yet, in a 25,000-square-foot West Dallas laboratory, dozens of geneticists, biologists, AI experts and more work day in and day out to turn science ...
Colossal, which is trying to revive the dodo and woolly mammoth, has $10.2 billion valuation after Dodger owner and Legendary founder back company's de-extinction work ...
Colossal BioSciences has raised $200 million in a new round of funding to bring back extinct species like the woolly mammoth.
The company’s three active de-extinction projects include the woolly mammoth, the dodo bird and the thylacine (also known as the Tasmanian tiger), a dog-like carnivorous marsupial with stripes.
Inside, between rows of incubators and microscopes, Beth Shapiro and her team are attempting a feat straight out of science fiction: reviving the dodo, a bird that’s been extinct for more than ...